A gain of function p53 gene mutant promotes growth suppression in human liver cancer cells
Primary liver cancer is one of the most common cancer in the world with highest cancer mortality rate. The most common type of primary liver cancer is hepatocellular carcinoma (HCC). There are many risk factors for liver cancer and currently available treatments for HCC are largely inadequate. Gene...
Main Authors: | Nor Adzimah Johdi, Siti Nurmi Nasir, A. Rahman A. Jamal |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2017
|
Online Access: | http://journalarticle.ukm.my/11149/1/15%20Nor%20Adzimah%20Johdi.pdf |
Similar Items
-
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion
by: Jin Zhang, et al.
Published: (2024-01-01) -
c-Abl, an accomplice in mutant p53 gain-of-function?
by: Liu, Di
Published: (2014) -
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
by: Ramona Schulz-Heddergott, et al.
Published: (2018-06-01) -
Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
by: Katarzyna A. Roszkowska, et al.
Published: (2022-10-01) -
Regulators of Oncogenic Mutant TP53 Gain of Function
by: Satomi Yamamoto, et al.
Published: (2018-12-01)